Jean‐Marc Barret

Triptolide is an inhibitor of RNA polymerase I and II–dependent transcription leading predominantly to down-regulation of short-lived mRNA

Stéphane Vispé, Luc DeVries, Laurent Créancier et al. · Molecular Cancer Therapeutics · 2009 · 186 citations · Full text

Medicine, Molecular Biology, Oncology +13

Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid

Anna Kruczynski, Jean‐Marc Barret, Chantal Etiévant et al. · Biochemical Pharmacology · 1998 · 147 citations

Medicine, Medicinal Chemistry, Pharmacology +11

F14512, a Potent Antitumor Agent Targeting Topoisomerase II Vectored into Cancer Cells via the Polyamine Transport System

Jean‐Marc Barret, Anna Kruczynski, Stéphane Vispé et al. · Cancer Research · 2008 · 95 citations · Full text

Medicine, Oncology, Pharmacology +14

F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action

Dominique Perrin, B van Hille, Jean‐Marc Barret et al. · Biochemical Pharmacology · 2000 · 87 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

Vinflunine (20′,20′-difluoro- 3′,4′-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro

Chantal Etiévant, Jean‐Marc Barret, Anna Kruczynski et al. · Investigational New Drugs · 1998 · 68 citations

Medicine, Medicinal Chemistry, Pharmacology +10